DOI QR코드

DOI QR Code

Synergistic Anticancer Activity of 5-Aminolevulinic Acid Photodynamic Therapy in Combination with Low-dose Cisplatin on Hela Cells

  • Wei, Xiao-Qiang (Department of Gynecology and Obstetrics, Qilu Hospital, Shandong University) ;
  • Ma, Hui-Qing (Department of Gynecology and Obstetrics, The Second Affiliated Hospital of Qingdao University Medical College) ;
  • Liu, Ai-Hong (Department of Gynecology and Obstetrics, Qingdao Haici Medical Group) ;
  • Zhang, You-Zhong (Department of Gynecology and Obstetrics, Qilu Hospital, Shandong University)
  • Published : 2013.05.30

Abstract

Objective: Photodynamic therapy (PDT ) is a promising modality for the treatment of various tumors. In order to assist in optimizing treatment, we applied 5-ALA/PDT in combination with low-dose cisplatin to evaluate cytotoxicity in Hela cells. Methods: Antiproliferative effects of 5-ALA/PDT and cisplatin, alone and in combination, were assessed using MTT assay. To examine levels of apoptosis, Hela cells treated with 5-ALA/PDT, and combination treatment were assessed with Annexin-V/PI by flow cytometry. To investigate the molecular mechanisms underlying alterations in cell proliferation and apoptosis, Western blot analysis was conducted to determine the expression of p53, p21, Bax and Bcl-2 proteins. Results: MTT assays indicated that combination treatment obviously decreased the viability of Hela cells compared to individual drug treatment. In addition, it was confirmed that exposure of Hela cells to 5-ALA/PDT in combination with low-dose cisplatin resulted in more apoptosis in vitro. Synergistic anticancer activity was related to upregulation p53 expression and alteration in expression of p21, Bcl-2 and Bax. Conclusion: Our findings suggest that administration of 5-ALA/PDT in combination with the low-dose cisplatin may be an effective and feasible therapy for cervical cancer.

Keywords

References

  1. Chen HM, Liu CM, Yang H, et al (2011a). 5-aminolevulinic acid induce apoptosis via NF-kappaB/JNK pathway in human oral cancer Ca9-22 cells. J Oral Pathol Med, 40, 483-9. https://doi.org/10.1111/j.1600-0714.2010.00973.x
  2. Chen X, Zhao P, Chen F, Li L, and Luo R (2011b). Effect and mechanism of 5-aminolevulinic acid-mediated photodynamic therapy in esophageal cancer. Lasers Med Sci, 26, 69-78. https://doi.org/10.1007/s10103-010-0810-0
  3. Compagnin C, Mognato M, Celotti L, et al (2010). Cell proliferation and cell cycle alterations in oesophageal p53-mutated cancer cells treated with cisplatin in combination with photodynamic therapy. Cell Prolif, 43, 262-74. https://doi.org/10.1111/j.1365-2184.2010.00673.x
  4. Crescenzi E, Chiaviello A, Canti G, et al (2006). Low doses of cisplatin or gemcitabine plus Photofrin/photodynamic therapy, Disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299). Mol Cancer Ther, 5, 776-85. https://doi.org/10.1158/1535-7163.MCT-05-0425
  5. Crescenzi E, Varriale L, Iovino M, et al (2004). Photodynamic therapy with indocyanine green complements and enhances low-dose cisplatin cytotoxicity in MCF-7 breast cancer cells. Mol Cancer Ther, 3, 537-44. https://doi.org/10.4161/cbt.3.6.845
  6. Danial NN, Korsmeyer SJ (2004). Cell death, critical control points. Cell, 116, 205-19. https://doi.org/10.1016/S0092-8674(04)00046-7
  7. Davila ML. (2011). Photodynamic therapy. Gastrointest Endosc Clin N Am, 21, 67-79. https://doi.org/10.1016/j.giec.2010.09.002
  8. Fu KK, DeGregorio MW, Phillips JW (1988). Plasma and tumor concentrations of cisplatin following intraperitoneal infusion or bolus injection with or without continuous low-dose-rate irradiation. NCI Monogr, 6, 123-7.
  9. Garland SM, Bhatla N, Ngan HY (2012). Cervical cancer burden and prevention strategies, Asia Oceania perspective. Cancer Epidemiol Biomarkers Prev, 21, 1414-22. https://doi.org/10.1158/1055-9965.EPI-12-0164
  10. Ge R, Ahn JC, Shin JI, et al (2011). An in vitro and in vivo study of combination therapy with Photogem(R)-mediated photodynamic therapy and cisplatin on mouse cancer cells (CT-26). Photomed Laser Surg, 29 , 155-60. https://doi.org/10.1089/pho.2009.2750
  11. Gomer CJ, Dougherty TJ (1979). Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res, 39, 146-51.
  12. Gui T, Wang Y, Mao Y, et al (2012). Comparisons of 5-aminolevulinic acid photodynamic therapy and afterloading radiotherapy in vivo in cervical cancer. Clin Transl Oncol, 15, 434-42.
  13. He GF, Bian ML, Zhao YW, et al (2008). Apoptosis-inducing effect of 5-aminolevulinic acid-mediated photodynamic therapy (5-ALA-PDT) on cervical cancer cell lines. Ai Zheng, 27, 897-904.
  14. He GF, Bian ML, Zhao YW, et al (2009). A study on the mechanism of 5-aminolevulinic acid photodynamic therapy in vitro and in vivo in cervical cancer. Oncol Rep, 21, 861-8.
  15. Ishizuka M, Abe F, Sano Y, et al (2011). Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy. Int Immunopharmacol, 11, 358-65. https://doi.org/10.1016/j.intimp.2010.11.029
  16. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  17. Jemal A, Murray T, Samuels A, et al (2003). Cancer statistics, 2003. CA Cancer J Clin, 53, 5-26. https://doi.org/10.3322/canjclin.53.1.5
  18. Ke QH, Zhou SQ, Du W, et al (2012). Early efficacy of taxotere and cisplatin chemo-radiotherapy for advanced cervical cancer. Asian Pac J Cancer Prev, 13, 617-9. https://doi.org/10.7314/APJCP.2012.13.2.617
  19. Kim YW, Bae SM, Battogtokh G, Bang HJ, Ahn WS (2012). Synergistic anti-tumor effects of combination of photodynamic therapy and arsenic compound in cervical cancer cells, in vivo and in vitro studies. PLoS One, 7, e38583. https://doi.org/10.1371/journal.pone.0038583
  20. Lagrange JL, Bondiau PY, Tessier E, et al (1996). Tumoral platinum concentrations in patients treated with repeated low-dose cisplatin as a radiosensitizer. Int J Cancer, 68, 452-6. https://doi.org/10.1002/(SICI)1097-0215(19961115)68:4<452::AID-IJC9>3.0.CO;2-#
  21. Liu Y, Xing H, Han X, et al (2008). Apoptosis of HeLa cells induced by cisplatin and its mechanism. J Huazhong Univ Sci Technolog Med Sci, 28, 197-9. https://doi.org/10.1007/s11596-008-0221-7
  22. Massague, J. (2004). G1 cell-cycle control and cancer. Nature, 432, 298-306. https://doi.org/10.1038/nature03094
  23. Oleinick NL, Morris RL, Belichenko I (2002). The role of apoptosis in response to photodynamic therapy, what, where, why, and how. Photochem Photobiol Sci, 1, 1-21. https://doi.org/10.1039/b108586g
  24. Peng Q, Warloe T, Berg K, et al (1997). 5-Aminolevulinic acidbased photodynamic therapy. Clinical research and future challenges. Cancer, 79, 2282-308. https://doi.org/10.1002/(SICI)1097-0142(19970615)79:12<2282::AID-CNCR2>3.0.CO;2-O
  25. Rabik CA, Dolan ME (2007). Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev, 33, 9-23. https://doi.org/10.1016/j.ctrv.2006.09.006
  26. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990). The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63, 1129-36. https://doi.org/10.1016/0092-8674(90)90409-8
  27. Schloffer D, Horky M, Kotala V, Wesierska-Gadek J (2003). Induction of cell cycle arrest and apoptosis in human cervix carcinoma cells during therapy by cisplatin. Cancer Detect Prev, 27, 481-93. https://doi.org/10.1016/j.cdp.2003.07.002
  28. Suo Z, Lippard SJ, Johnson KA (1999). Single d(GpG)/cisdiammineplatinum(II) adduct-induced inhibition of DNA polymerization. Biochemistry, 38, 715-26. https://doi.org/10.1021/bi981854n
  29. Suprasert P, Thongsong T, Srisomboon J, Chailert C (2007). Efficacy of cisplatin in early stage cervical cancer with a long waiting period for surgery. Asian Pac J Cancer Prev, 8, 51-4.
  30. Tsai JC, Wu CL, Chien HF, Chen CT (2005). Reorganization of cytoskeleton induced by 5-aminolevulinic acid-mediated photodynamic therapy and its correlation with mitochondrial dysfunction. Lasers Surg Med, 36, 398-408. https://doi.org/10.1002/lsm.20179
  31. Tsai T, Ji HT, Chiang PC, et al (2009). ALA-PDT results in phenotypic changes and decreased cellular invasion in surviving cancer cells. Lasers Surg Med, 41, 305-15. https://doi.org/10.1002/lsm.20761
  32. Uehara M, Inokuchi T, Ikeda H (2006). Enhanced susceptibility of mouse squamous cell carcinoma to photodynamic therapy combined with low-dose administration of cisplatin. J Oral Maxillofac Surg, 64, 390-6. https://doi.org/10.1016/j.joms.2005.11.011
  33. Wesierska-Gadek J, Schloffer D, Kotala V, et al (2002). Escape of p53 protein from E6-mediated degradation in HeLa cells after cisplatin therapy. Int J Cancer, 101, 128-36. https://doi.org/10.1002/ijc.10580
  34. Yow CM, Wong CK, Huang Z, Ho RJ (2007). Study of the efficacy and mechanism of ALA-mediated photodynamic therapy on human hepatocellular carcinoma cell. Liver Int, 27, 201-8. https://doi.org/10.1111/j.1478-3231.2006.01412.x

Cited by

  1. Two combined photosensitizers: a goal for more effective photodynamic therapy of cancer vol.5, pp.3, 2014, https://doi.org/10.1038/cddis.2014.77
  2. Low-dose cisplatin administration to septic mice improves bacterial clearance and programs peritoneal macrophage polarization to M1 phenotype pp.2049632X, 2014, https://doi.org/10.1111/2049-632X.12189
  3. Potential Molecular Mechanisms Involved in 5-Aminolevulinic Acid–Based Photodynamic Therapy against Human Hypertrophic Scars vol.136, pp.4, 2015, https://doi.org/10.1097/PRS.0000000000001626
  4. Photodynamic Therapy and Its Role in Combined Modality Anticancer Treatment vol.14, pp.4, 2015, https://doi.org/10.1177/1533034614556192
  5. Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis—a possible adjunct therapy vol.36, pp.11, 2015, https://doi.org/10.1007/s13277-015-3571-3
  6. 5-Aminolevulinic acid photodynamic therapy in human cervical cancer via the activation of microRNA-143 and suppression of the Bcl-2/Bax signaling pathway vol.14, pp.1, 2016, https://doi.org/10.3892/mmr.2016.5248
  7. A Strategy Using Photodynamic Therapy and Clofibric Acid to Treat Peritoneal Dissemination of Ovarian Cancer vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.775